CEACAM1 and neoplasm: F. nucleatum further inhibits the anti‐tumor activity of some TILs and NK cells that reach the tumor site by activating the human TIGIT checkpoint by utilizing a non‐lectin domain of the fusobacterial Fap2116 and the human CEACAM1 checkpoint via fusobacterial CbpF.117, 118, 119